Surgery is the gold standard for treating basal cell carcinomas (BCCs), however in cases of positive tumor margins or recurrent disease, postoperative adjuvant or salvaging therapy is prefered to achieve good local control. In their paper “Orthovoltage X-rays for...
Radiation-induced erectile-dysfunction (RiED) is one of the most common side effects of radiation therapy and significantly reduces the quality of life of cancer patients. Approximately 50% of prostate cancer patients experience RiED within 3 to 5 years after...
Kaposi's sarcoma is a rare cancer type caused by virus. Its main symptom is lesions - purplish, reddish blue or dark brown/black macules, plaques or nodules which present on the skin and occasionally internal organs. Though unable to be cured completely the lesions...
As skin cancer rates increase worldwide, with a predominance of head and neck cancers of varying levels of advance (80%) due to significant sun exposure to the area, and with an aging population and extended life expectancy, standard treatment regimens can be...
[vc_row type="in_container" full_screen_row_position="middle" scene_position="center" text_color="dark" text_align="left" overlay_strength="0.3" shape_divider_position="bottom" bg_image_animation="none"][vc_column column_padding="no-extra-padding"...
Radiotherapy remains one of many treatment options available for patients diagnosed with non-melanoma skin cancer (NMSC). NMSC is a radiation-responsive cancer and patients treated with definitive radiotherapy can expect excellent local control rates of >90–95%....
Chemotherapy and Radiotherapy utilize DNA-PK and PARP inhibitors to sensitize cancer cells, however these inhibitors have so far only been limited to homologous recombination repair deficient tumors, exploiting synthetic lethality. In the study “Sensitizing ewing...
Since October 2017, the radiation clinic and MVZ radiotherapy at the Sana Klinikum Offenbach have a new orthovolt device for X-ray irradiation. "We are pleased to be able to offer our patients another treatment option with the new device," explains chief physician...
January 31st, 2018 – Xstrahl, the leader in X-Ray Technology for treatment of Superficial Skin conditions is pleased to offer the new RADiant therapy system to Physician’s in America. Representing the next generation of compact radiotherapy systems, RADiant’s dual...
Contact Us